Yale doctor on FDA approval of Pfizer’s COVID vaccine as hospitalizations hit highest levels yet for kids, adults


(WTNH) – In Health Headlines, it’s all eyes on the full approval from the FDA on the Pfizer Biotech vaccine. Also, is COVID here for the long haul?

The FDA has granted full approval for Pfizer’s COVID-19 vaccine. Dr. Thomas Murray, Yale Medicine Pediatric Infectious Diseases Specialist and Associate Professor of Pediatrics at Yale School of Medicine spoke to News 8 about the approval.

“It shows the FDA has reviewed all of the new information and tout it to be a highly safe and efficacious vaccine, which we all kind of suspected as we’ve been through this,” Dr. Murray said.

WEB EXTRA: Full interview with Dr. Murray

Monday’s decision could pave the way for more vaccine mandates in both public and private sectors, and it could also help with vaccine hesitency.

“I hope it encourages those who have been hesitant about getting the vaccine and provides some reassurance, so they can go ahead and get safely vaccinated,” Dr. Murray said.

What does this mean for those who got Moderna or Johnson & Johnson?

“I would expect them to be close behind. Pfizer was one of the first vaccines that came out and was on the market, so I would expect those to follow behind,” Dr. Murray explained.

As for if COVID will be a forever thing, Dr. Murray said, “Great question because forever is a long time. I think what we can say safely is it’s going to be here for the foreseeable future. With FDA approval of vaccination today and hopefully the approval for children in the relatively near future.”

Copyright 2021 Nexstar Media Inc. All rights reserved. This material may not be published, broadcast, rewritten, or redistributed.

Trending Stories

Don't Miss

More Don't Miss